Raymond James & Associates Gilead Sciences, Inc. Call Options Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

Call Options

16 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 08, 2023	SELL	$62.32 - $89.47 $2.16 Million - $3.1 Million	-34,700 Reduced 50.73%	33,700 $2.89 Million
Q3 2022 Oct 25, 2022	SELL	$59.54 - $68.01 $708,526 - $809,319	-11,900 Reduced 14.82%	68,400 $66,000
Q2 2022 Aug 12, 2022	BUY	$57.72 - $65.01 $721,500 - $812,625	12,500 Added 18.44%	80,300 $120,000
Q1 2022 May 11, 2022	BUY	$57.92 - $72.58 $1.28 Million - $1.6 Million	22,100 Added 48.36%	67,800 $34,000
Q4 2021 Feb 08, 2022	BUY	$64.88 - $73.64 $123,271 - $139,916	1,900 Added 4.34%	45,700 $26,000
Q3 2021 Nov 02, 2021	BUY	$67.69 - $73.03 $724,283 - $781,421	10,700 Added 32.33%	43,800 $73,000
Q2 2021 Aug 11, 2021	BUY	$63.47 - $69.35 $1.31 Million - $1.43 Million	20,600 Added 164.8%	33,100 $19,000
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $1.12 Million - $1.28 Million	-18,700 Reduced 59.94%	12,500 $3,000
Q2 2020 Jul 28, 2020	SELL	$72.34 - $84.0 $7,234 - $8,400	-100 Reduced 0.32%	31,200 $33,000
Q1 2020 Apr 21, 2020	SELL	$62.63 - $80.22 $56,367 - $72,198	-900 Reduced 2.8%	31,300 $28,000
Q3 2019 Nov 07, 2019	SELL	$62.51 - $69.0 $162,526 - $179,400	-2,600 Reduced 7.47%	32,200 $7,000
Q2 2019 Aug 06, 2019	BUY	$61.87 - $69.38 $705,318 - $790,932	11,400 Added 48.72%	34,800 $31,000
Q1 2019 May 06, 2019	SELL	$62.53 - $70.05 $12,506 - $14,010	-200 Reduced 0.85%	23,400 $5,000
Q4 2018 Feb 11, 2019	SELL	$60.54 - $79.0 $823,344 - $1.07 Million	-13,600 Reduced 36.56%	23,600 $3,000
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $1.85 Million - $2.05 Million	26,000 Added 232.14%	37,200 $40,000
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $807,632 - $957,264	11,200	11,200 $30,000

Others Institutions Holding GILD

# of Institutions

1,931

Shares Held

991M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$10.8 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.4 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$6.88 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.55 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.41 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account